{
    "applicationNumber": "BR 11 2021 024157-4",
    "filingDate": "29/05/2020",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00d5ES IMUNOTERAP\u00caUTICAS PARA TRATAMENTO DE GLIOBLASTOMA MULTIFORME",
    "nationalPhaseDate": [
        "30/11/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT IB2020/000425",
        "pctDate": "29/05/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/855,120",
            "priorityDate": "31/05/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2657"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2666"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2677"
        }
    ],
    "inventors": [
        "DAVID EVANDER ANDERSON"
    ],
    "holders": [
        79991
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/00",
        "A61P 37/04",
        "C12N 15/62",
        "A61K 39/385",
        "C07K 19/00",
        "A61K 38/19",
        "C12N 7/00",
        "C07K 14/14",
        "C07K 14/535",
        "C07K 14/045"
    ]
}